Christina Farr and Stephanie Davis dig into what is really driving digital health with Rock Health Advisory CEO Megan Zweig and Aidoc CFO Arvind Kadaba: $7.4B in H1 2026 funding, mega deals absorbing 45% of all capital, and what counts as a differentiator once “AI-enabled” means nothing.
Dr. Zeyad Baker, a pediatrician who scaled a 24-hour primary care practice, sold it to Optum, and spent five years as their tri-state market CEO, joins Christina Farr to argue that the scarcest resource in healthcare is not data or technology but the doctor-patient relationship itself.
Plus an update on Second Opinion’s growth
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved
What the rise and fall of the hedge fund Situational Awareness tells us about the market
We’re live. Welcome to the all-new Second Opinion.
Matthew Rothstein, VP of Engineering at Akido, joins Christina Farr to talk about what changes when a technology company becomes a health system.
Passive advisors are out, co-builders are in.
Mark Bertolini, CEO of Oscar Health, joins Chrissy to unpack healthcare’s broken employer-sponsored system, the future of portable coverage, ICHRA, and the personal story that shaped his push for hospice reform at Aetna.
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management,
